Trends in cause of death among patients with renal cell carcinoma in the United States
A Seer-based study
Bibliographic Data
| ID | 15367152 |
|---|---|
| Authors | Xiangpeng Zhan (0000-0001-6872-3705, Nanchang University), Tao Chen (0000-0001-9162-4078, Nanchang University), Ying Liu (0000-0001-5584-7805, Hubei University of Medicine), Hao Wan (0000-0001-9703-3391, First Affiliated Hospital of Nanchang University), Xiaoqiang Liu (0000-0003-4459-2506, Nanchang University), Xinxi Deng (Jiujiang First People's Hospital, corresponding author), Bin Fu (0000-0001-6686-7561, Nanchang University), Jing Xiong (0000-0002-5007-8581, First Affiliated Hospital of Nanchang University) |
| Year | 2023 |
| Volume | 23 |
| Issue | 1 |
| Pages | 770-770 |
| Publication date | 2023-04-26 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | BMC Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1471-2458 • E-ISSN: 1471-2458 |
| Publisher | BioMed Central (PUBLISHER • GB) |
| DOI | 10.1186/s12889-023-15647-2 |
| PMID | 37101189 |
| OpenAlex | W4367054647 |
| Language | EN |
| References cited | 24 |
RCC was still the primary COD of patients with RCC. However, non-RCC cause death was increasingly important among RCC patients in recent two decades. Cardiovascular disease and other cancers were crucial co-morbidities that required significant attention in the management of RCC patients
Cancer · Cause of death · Disease · Incidence (geometry · Mortality rate · Renal cell carcinoma · Economic and Financial Impacts of Cancer · Medicine · Multiple and Secondary Primary Cancers · Renal cell carcinoma treatment · Epidemiology · Internal Medicine · Oncology
| Citation velocity | historical |
|---|---|
| Highly cited | No |